India Business Information

Corona News



COVAXIN is India’s 'first' indigenous COVID-19 vaccine

India has finally developed its first indigenous COVID-19 vaccine named COAXIN. A Hyderabad-based company called Bharat Biotech has achieved this success in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology, Pune. The recently developed coronavirus vaccine has got the approval for human trials by the Drug Controller General of India (DCGI).
The DGCI, CDSCO (Central Drugs Standard Control Organisation), and Ministry of Health and Family Welfare granted permission to initiate Phase I and II human clinical trials after the company submitted results generated from pre-clinical studies, demonstrating safety and immune response.
The Phase I and Phase II clinical trials of the vaccine for SARS-CoV-2 are scheduled to start across India in July.
Hits: 3769, Rating : India ( 5 ) by 1 User(s).